skip to Main Content
Advantage And Pitfalls Of Mini-invasive Resections For HCC: Which Is The Future Prospective?

Advantage and pitfalls of mini-invasive resections for HCC: which is the future prospective?

Map Unavailable

Date/Time
Date(s) - 19/10/2022
4:00 pm

Categories


With great pleasure I would like to send you the program of the next 3 webinars that the Italian group HE.RC.O.LE.S. organizes on the HCC.

Each webinar is designed as a round table, where, following two presentations made by two international experts, a debate will be opened on some of the hottest topics concerning the hepatocellular carcinoma. Among the guests, several international colleagues with whom we will discuss. The faculty is of great value, and the resulting debates will try to open an innovative space for discussion, which nourishes the comparison between different ideas and philosophies.

Participation in the webinars will be free for everyone, just register (in the pdf, you can click on the registration buttons). Find more information at https // webinars.hercolesgroup.eu.

The webinars will be (Rome time):

– 20 September 2022 h 17: Treating HCC outside the BCLC guidelines:
should we change the treatment algorithm?
– 19 October 2022 h16: Advantage and pitfalls of mini-invasive resections
for HCC: which is the future prospective?
– November 23, 2022 h16: How to boost the recovery after hepatectomy for HCC:
From preoperative assessment to enhanced postoperative care.

You are all invited, and we hope you will be able to disseminate these initiatives in your schools and among your colleagues.
Hoping to please you,
See you from September!

 

Fabrizio Romano, MD
School of Medicine and Surgery, University of Milan-Bicocca, Italy

Simone Famularo, MD, PhD cand.
Hepatobiliary and general Surgery Division, IRCCS Humanitas Research Hospital (MI), Italy

on behalf of HE.RC.O.LE.S. Group
Hepatocellular carcinoma recurrence on the liver Study group

Back To Top